Author

V. Benoit

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Pharmacology & Toxicology· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 3 Research Focus:host-pathogen & immune response· 2 Assay:proteomics· 2 Research Focus:cell type annotation· 1 Organism:human· 1 Research Focus:metabolism & bioenergetics· 1 Assay:metabolomics· 1

Frequent Co-Authors

M. Foretz· 2 shared A. E. Pollard· 1 shared C. Beall· 1 shared C. O'Dwyer· 1 shared D. Carling· 1 shared E. E. Mulvihill· 1 shared F. Nielsen· 1 shared J. B. Birk· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPhysiology

M. Foretz

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Pharmacological AMP-activated protein kinase activation suppresses low glucose-dependent macrophage migration inhibitory factor release from macrophages

J. Zhang, A. E. Pollard, D. Carling, V. Benoit, K. L. Ellacott, C. Beall

This study shows that activating AMPK reduces MIF release from macrophages under low glucose conditions by inhibiting NFB signaling.

bioRxiv · Oct 16, 2023 · PreprintPharmacology & Toxicology

Metformin improves glycemia independently of skeletal muscle AMPK via enhanced intestinal glucose clearance

R. Kjobsted, J. M. Kristensen, J. B. Birk, N. O. Jorgensen, K. Kido, N. R. Andersen, J. K. Larsen, M. Foretz, V. Benoit, F. Nielsen, K. Brosen, N. Jessen, Y. Hellsten, K. Hojlund, J. F. P. Wojtaszewski

This study shows metformin reduces blood glucose through improved intestinal glucose clearance, not via skeletal muscle AMPK activation, challenging current understanding of its mechanism.

bioRxiv · May 22, 2022 · PreprintPhysiology

Myeloid deletion and therapeutic activation of AMP-activated protein kinase (AMPK) do not alter atherosclerosis in male or female mice

N. D. LeBlond, P. Ghorbani, C. O'Dwyer, N. Ambursley, J. R. Nunes, T. K. Smith, N. A. Trzaskalski, E. E. Mulvihill, V. Benoit, M. Foretz, M. D. Fullerton

This study shows that deleting AMPK in myeloid cells or activating it therapeutically does not affect atherosclerosis in male or female mice.

bioRxiv · Jul 15, 2020 · PreprintBiochemistry